Florastor is a yeast in a capsule, and its origin story is a fruit drink. Biocodex tells it like this: in the early 1920s the French microbiologist Henri Boulard, posted to French Indochina, saw people drink a preparation of lychees and mangosteens for the digestive troubles of cholera, and in 1923 he isolated the yeast that bears his name. Biocodex bought the rights in 1953, registered the strain at the Institut Pasteur as CNCM I-745 in 1988, and has sold it in France as the medicine Ultra-Levure and, since 2002, in North America as the supplement Florastor.
Its yeast, Saccharomyces boulardii, is taxonomically a form of baker's yeast, which makes Florastor a cousin of every beer and bread in the world, and of the yeasts in kefir and kumis one family over. It has the best evidence of any product in this batch, for one specific use: preventing antibiotic diarrhoea in children, at moderate certainty. It also has the clearest warning: France rules it out for critically ill and immunocompromised patients and anyone with a central line, after rare yeast bloodstream infections. Same yeast family, very different vehicles: a loaf, a pint, and a freeze-dried capsule.
Sources: Biocodex (Florastor)maker
What's in it
One active ingredient, a single named strain. The full excipient list of the US capsules couldn't be read (the site rate-limited automated requests); the French Ultra-Levure capsule's excipients are given under its variant.
Watch out
And from the botanicals inside, as noted on their own pages. Amounts in a capsule differ, but these are worth knowing:
Saccharomyces boulardii: AvoidRare but sometimes fatal yeast bloodstream infections (fungaemia) have been reported in critically ill or immunocompromised hospital patients taking S. boulardii, and in people with central venous catheters. France contraindicates it for all three groups, and warns that the yeast can spread on hands or through the air to nearby patients, so capsules and sachets shouldn't be opened in their rooms. A Finnish study found that at least 43% of patients with Saccharomyces fungaemia had been taking the probiotic. For: critically ill, immunocompromised, central venous catheter, people nursing them.2 more notes on its page
Over the years
Ultra-Levure (France)
France · current
Biocodex's original French medicine, sold as 50 mg and 200 mg capsules and 100 mg sachets for adjunct treatment of diarrhoea alongside rehydration. The 50 mg capsule contains sucrose, magnesium stearate and lactose monohydrate as excipients. Since 2018 it has been contraindicated in critically ill and immunocompromised patients, as well as with central venous catheters. Its launch date isn't given here: Biocodex's own history page refused automated readers.
Sources: ANSM 2014regulatorANSM (letter to health professionals from… 2018regulator
The evidence
S. boulardii (mostly CNCM I-745) taken with antibiotics, to prevent diarrhoea
European paediatric gastroenterologists (ESPGHAN), reviewing strain-specified trials with GRADE, rated the evidence that S. boulardii prevents antibiotic-associated diarrhoea in children as moderate quality and recommended it. A 2015 meta-analysis found it cut the risk in children from about 21% to 9%.
Sources: Journal of Pediatric Gastroenterology and… 2016clinical guidelineAlimentary Pharmacology & Therapeutics 2015systematic review
S. boulardii taken with antibiotics, to prevent diarrhoea
A 2015 meta-analysis of 15 trials in 3114 adults found S. boulardii cut antibiotic-associated diarrhoea from about 17% to 8%, though not C. difficile diarrhoea; its abstract doesn't give a certainty rating for adults.
Sources: Alimentary Pharmacology & Therapeutics 2015systematic review
LooseSome evidencevery low certainty · children with acute gastroenteritis S. boulardii during acute gastroenteritis, alongside rehydration
A 2020 meta-analysis of 29 trials found children had diarrhoea for about a day less on S. boulardii, but rated the evidence low to very low quality.
Sources: Alimentary Pharmacology & Therapeutics 2020systematic review
And for saccharomyces boulardii itself
- Saccharomyces boulardii Studied & supported for loose · S. boulardii (mostly CNCM I-745) capsules or sachets taken with antibiotics, to…